Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Jun 15 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 4,062 | $450.00 | $1.8M | -19.3% | Open the original filing on SEC.gov |
| Jun 5 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,745 | $450.00 | $785.3K | -7.7% | Open the original filing on SEC.gov |
| May 29 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,974 | $450.00 | $888.3K | -8.0% | Open the original filing on SEC.gov |
| May 15 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,354 | $453.45 | $614K | -5.2% | Open the original filing on SEC.gov |
| May 12 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 6,988 | $450.00 | $3.1M | -21.1% | Open the original filing on SEC.gov |
| Mar 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,329 | $450.95 | $1.1M | -6.6% | Open the original filing on SEC.gov |